Biovie BIVI
NASDAQ BIVI
$1.46 -0.01 (-0.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biovie (BIVI) Interest & Investment Income (2013 - 2026)

Updated

Biovie (BIVI) recorded Interest & Investment Income of $77,902 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 56.5% from $178,942 a year earlier and down 35.6% from the prior quarter.

Analysis

Biovie (BIVI) Interest & Investment Income (2013 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Biovie reported Interest & Investment Income of $596,771, down 30.0% from FY2025.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 93.5% (FY2021 to FY2026).
  • Across earlier fiscal years, Interest & Investment Income came in at $853,029 in FY2025 (-25.0%), $1.14 million in FY2024 (+102.2%), $562,264 in FY2023 and $44,080 in FY2022 (+100.6%).
  • The fiscal Q4 2026 figure is the lowest quarterly Interest & Investment Income since fiscal Q1 2023.
  • On a year-over-year basis, Interest & Investment Income has declined for five consecutive quarters, with an average decline of 23.8% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 611.6% in fiscal Q2 2023, against a decline of 56.5% in fiscal Q4 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $121,045 (Q3 2026), $198,797 (Q2 2026) and $199,027 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biovie 11.01 Mn 11.01 Mn - 77,902.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77,902.00
Mar 31, 2026 121,045.00
Dec 31, 2025 198,797.00
Sep 30, 2025 199,027.00
Jun 30, 2025 178,942.00
Mar 31, 2025 197,494.00
Dec 31, 2024 253,036.00
Sep 30, 2024 223,557.00
Jun 30, 2024 272,517.00
Mar 31, 2024 183,933.00
Dec 31, 2023 218,029.00
Sep 30, 2023 462,223.00
Jun 30, 2023 255,209.00
Mar 31, 2023 182,201.00
Dec 31, 2022 83,269.00
Sep 30, 2022 41,585.00
Jun 30, 2022 11,459.00
Mar 31, 2022 13,273.00
Dec 31, 2021 11,702.00
Sep 30, 2021 7,645.00
API Access

Biovie Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BIVI&period=max&api_key=YOUR_API_KEY